1972
DOI: 10.1107/s056774087200651x
|View full text |Cite
|
Sign up to set email alerts
|

Structure of a bis-bidentate metal complex, bis-(N-t-butylpyrrole-2-carbaldimino)nickel(II). Analysis of its configurational disorder in the crystalline state

Abstract: The crystal and molecular structure of a bis-bidentate nickel complex, (CgHI3N2)zNi(II), has been determined from a single-crystal X-ray analysis. The unit-cell data are a= 16-777 (13), b=7.507 (6), c= 15.378 (11) A, Z=4, space group Pbcn. Counter data to 20=48 ° (Mo K~ radiation) were measured with an Oak Ridge computer-controlled diffractometer. The structure was solved by heavy-atom techniques and refined by the full-matrix least-squares method to R(F)= 0"102, based on 1160 independent nonzero reflections, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

1983
1983
2023
2023

Publication Types

Select...
4
2
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(8 citation statements)
references
References 6 publications
0
8
0
Order By: Relevance
“…[4][5][6] Such ligands stabilize metal ions in a range of oxidation states. [7] Examples include structurally characterized Co II/III , [8][9][10][11] Rh I/III , [12][13][14][15] Ir III , [16,17] Ni II , [18][19][20] Pd II , [20][21][22] Pt II , [23][24][25] Cu II , [26][27][28][29] Ag I , [30] and Au III complexes. [31] While pyrrole compounds are key building blocks for organic pharmaceuticals, [32] for example, Tolmetin, [33] Sunitinib, [34] and Glimepiride, [35] studies over the last two decades suggest that pyrrole-imine metal chelates exhibit significant medicinal potential.…”
Section: Introductionmentioning
confidence: 99%
“…[4][5][6] Such ligands stabilize metal ions in a range of oxidation states. [7] Examples include structurally characterized Co II/III , [8][9][10][11] Rh I/III , [12][13][14][15] Ir III , [16,17] Ni II , [18][19][20] Pd II , [20][21][22] Pt II , [23][24][25] Cu II , [26][27][28][29] Ag I , [30] and Au III complexes. [31] While pyrrole compounds are key building blocks for organic pharmaceuticals, [32] for example, Tolmetin, [33] Sunitinib, [34] and Glimepiride, [35] studies over the last two decades suggest that pyrrole-imine metal chelates exhibit significant medicinal potential.…”
Section: Introductionmentioning
confidence: 99%
“…[4][5][6] Such ligands stabilize metal ions in a range of oxidation states. [7] Examples include structurally characterized Co II/III , [8][9][10][11] Rh I/III , [12][13][14][15] Ir III , [16,17] Ni II , [18][19][20] Pd II , [20][21][22] Pt II , [23][24][25] Cu II , [26][27][28][29] Ag I , [30] and Au III complexes. [31] While pyrrole compounds are key building blocks for organic pharmaceuticals, [32] e.g., Tolmetin, [33] Sunitini, [34] and Glimepiri, [35] studies over the last two decades suggest that pyrrole-imine metal chelates exhibit significant medicinal potential.…”
Section: Introductionmentioning
confidence: 99%
“…5). It has been reported on the basis of X-ray single crystal studies of Ni(II) Schiff base complexes containing bulky groups attached to the coordinated azomethine nitrogen atoms, that they have distorted tetrahedral cores 8 . .…”
Section: Novel Symmetrical Schiff Base Ligands 901 Esr Spectra Of Thementioning
confidence: 99%